Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 23% ± 3% |
Insufficient scRNA-seq data for expression of PNPO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 559.99 | 966 / 966 | 100% | 15.95 | 527 / 527 |
kidney | 100% | 1274.09 | 89 / 89 | 100% | 17.69 | 901 / 901 |
liver | 100% | 2085.38 | 226 / 226 | 100% | 26.36 | 406 / 406 |
prostate | 100% | 563.65 | 245 / 245 | 100% | 14.13 | 502 / 502 |
thymus | 100% | 884.06 | 653 / 653 | 100% | 14.44 | 605 / 605 |
stomach | 100% | 528.00 | 358 / 359 | 100% | 15.84 | 286 / 286 |
brain | 100% | 798.65 | 2630 / 2642 | 100% | 15.32 | 705 / 705 |
esophagus | 100% | 542.80 | 1443 / 1445 | 99% | 13.42 | 182 / 183 |
breast | 100% | 646.95 | 459 / 459 | 99% | 19.01 | 1110 / 1118 |
skin | 100% | 587.22 | 1807 / 1809 | 99% | 10.43 | 469 / 472 |
bladder | 100% | 510.33 | 21 / 21 | 99% | 13.45 | 500 / 504 |
adrenal gland | 100% | 1206.77 | 258 / 258 | 99% | 13.26 | 228 / 230 |
uterus | 99% | 396.57 | 169 / 170 | 100% | 11.06 | 457 / 459 |
ovary | 99% | 439.01 | 179 / 180 | 99% | 14.16 | 427 / 430 |
lung | 99% | 514.40 | 574 / 578 | 99% | 11.57 | 1145 / 1155 |
pancreas | 100% | 483.78 | 327 / 328 | 98% | 9.53 | 175 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.91 | 29 / 29 |
muscle | 100% | 890.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 519.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.64 | 1 / 1 |
adipose | 100% | 523.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 404.98 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 9.12 | 78 / 80 |
heart | 94% | 516.00 | 806 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 431.62 | 657 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008615 | Biological process | pyridoxine biosynthetic process |
GO_0042823 | Biological process | pyridoxal phosphate biosynthetic process |
GO_0042818 | Biological process | pyridoxamine metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0010181 | Molecular function | FMN binding |
GO_0005515 | Molecular function | protein binding |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
GO_0004733 | Molecular function | pyridoxamine phosphate oxidase activity |
Gene name | PNPO |
Protein name | Pyridoxamine 5'-phosphate oxidase pyridoxal 5'-phosphate synthase (EC 1.4.3.5) Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase) |
Synonyms | |
Description | FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP). . FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP). . FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP). . FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP). . |
Accessions | ENST00000225573.5 [Q9NVS9-4] A0A286YFA1 ENST00000641703.1 ENST00000641709.1 J3QQZ9 ENST00000585320.5 [Q9NVS9-2] ENST00000642017.2 [Q9NVS9-1] ENST00000641856.1 [Q9NVS9-2] A0A286YF16 ENST00000582171.6 [Q9NVS9-2] A0A286YFL3 ENST00000583599.6 J3QQV6 ENST00000584061.6 ENST00000434554.7 [Q9NVS9-3] A0A286YF38 Q9NVS9 ENST00000641511.1 ENST00000641323.1 |